Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - June 2014


2nd Annual Discovery Chemistry & Drug Design Congress 2014

02 Jun 2014 - 03 Jun 2014 - Geneva, Switzerland



Bookmark and Share


Oxford Global Conferences are pleased to announce the 2nd Annual Discovery Chemistry & Drug Design Congress, taking place at the Intercontinental Geneva on 2 & 3 June 2014. This two day congress has been developed to offer discovery chemistry leaders an executive platform for networking and discussion. Our expert speakers will discuss methods of improving solubility, drugability and potency, while combatting the challenges of an increased demand for molecular complexity. Delegates will hear case studies covering a range of topics, including fragment based discovery, computer aided design for biologics and the role of natural products in discovery chemistry. The congress is part of the 15th Annual Drug Discovery Summit – Europe’s premier networking and discussion forum for pharmaceutical leaders. The congress is also co-located with the 6th Annual Drug Development Congress, a two day event focused on predictive science and translational medicine. Contact Danielle Dalby for more information on attendance, prices or to download the agenda on d.dalby@oxfordglobal.co.uk

Further information
Scientific News
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!